US Broker Ratings

Guardant Health, Inc. (GH) Investor Outlook: A 20% Upside Potential Amidst Rapid Revenue Growth

Guardant Health, Inc. (GH) stands at the forefront of the precision oncology sector, offering innovative solutions in diagnostics and research. With a significant market capitalization of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a Challenging Market with a -15.14% Potential Downside

For investors keeping a keen eye on the medical devices industry, Bio-Rad Laboratories, Inc. (NYSE: BIO) presents a fascinating case study. With a market capitalization of..

Ascendis Pharma A/S (ASND): Investor Outlook Reveals a Promising 27% Upside Potential in Biotech

Ascendis Pharma A/S (NASDAQ: ASND), a Danish biopharmaceutical company, has been making significant waves in the healthcare sector, particularly within the biotechnology industry. With a robust..

Bruker Corporation (BRKR) Stock Analysis: Exploring Growth Potential in the Healthcare Sector

Bruker Corporation (BRKR), a prominent player in the medical devices industry, has been making waves in the healthcare sector with its scientific instruments and analytical solutions...

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatile Waters of TCM Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a pioneering company in the healthcare sector, is capturing attention with its focus on Traditional Chinese Medicine (TCM) aimed at..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a 41.55% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its notable market presence and promising growth..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring a Biotech Giant with 18.87% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD) stands as a formidable entity in the biotechnology sector, commanding a significant market capitalization of $44.56 billion. Headquartered in Redwood City,..

Stevanato Group S.p.A. (STVN) Stock Analysis: Navigating a Potential 18% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. With a robust market..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 23% Upside Opportunity

HealthEquity, Inc. (NASDAQ: HQY) stands at the nexus of healthcare and technology, delivering innovative solutions through its comprehensive services platform. With a market capitalization of $7.97..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Revenue Growth and Promising Potential Upside for Investors

TG Therapeutics, Inc. (NASDAQ: TGTX) has recently captured the attention of investors with its strong revenue growth and potential upside. This biotechnology company, based in Morrisville,..

Quest Diagnostics (DGX) Stock Analysis: Navigating Growth Amidst a Competitive Landscape

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the Healthcare sector’s Diagnostics & Research industry, presents an intriguing case for investors seeking a blend of growth..

DaVita Inc. (DVA) Stock Analysis: Strong EPS and Growth Potential Highlight Investment Opportunity

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector specializing in kidney dialysis services, presents a compelling case for investors seeking exposure to the..

Lantheus Holdings, Inc. (LNTH): Analyst Consensus and Growth Potential Amid Healthcare Innovations

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector specializing in diagnostic and therapeutic products, is drawing attention in the investment community for..

Repligen Corporation (RGEN) Stock Analysis: Investor Optimism Backed by Strong Buy Ratings and Growth Potential

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector’s medical instruments and supplies industry, commands the attention of investors seeking robust growth opportunities in..

Genmab A/S (GMAB) Stock Report: Analyst Consensus Suggests 16.87% Upside Potential

Genmab A/S (GMAB), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising outlook and innovative pipeline. Headquartered in Copenhagen,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 15% Potential Upside with Strong Buy Ratings

As investors seek opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) stands out with a promising 15% potential upside, bolstered by a significant..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Through Biotechnology with High Return on Equity

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust revenue growth and exceptional return on..

Waystar Holding Corp. (WAY) Stock Analysis: Potential Upside of Over 26% Amid Strong Buy Ratings

Waystar Holding Corp. (NASDAQ: WAY), a prominent player in the healthcare information services sector, is drawing significant attention from investors, with its stock currently priced at..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Healthcare Landscape with a 4.56% Potential Upside

Molina Healthcare Inc (MOH), a prominent player in the healthcare plans industry, is garnering attention with its strategic focus on managed healthcare services for low-income families..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds